Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VNUS Medical predicts 2007 launch for faster vein closer catheter:

This article was originally published in Clinica

Executive Summary

VNUS Medical Technologies could be set to commercialise next year a faster version of its radiofrequency (RF) ablation catheter for closing diseased veins. So said the San Jose, California firm, after its first human trial of the new device, ClosureFAST, produced positive results. Over 30 patients were treated with the catheter under local anaesthetic at three European centres and all the treatments were successful at occluding the great saphenous vein, both acutely and at a three day post-procedure, the company reported. In addition, the catheter heated, shrunk and occluded the refluxing saphenous veins with RF ablation times of just three to five minutes, indicating that it could significantly speed up procedures, while providing patients the RF treatment benefit of rapid recovery with minimal or no discomfort.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT051962

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel